Baurs CEO appointed as Hon. Secretary at the Pharmaceutical Chamber For the first time in its history Baurs joined the board of Office Bearers of the Sri Lanka Chamber of the Pharmaceutical Industry (SLCPI) at the 58th annual general meeting (AGM) on 7th August 2019. With the appointment of Rolf Blaser, Managing Director/CEO of A. Baur & Co. (Pvt.) Ltd. as Hon. Secretary of SLCPI, Baurs confirms its commitment to the healthcare industry in Sri Lanka and receives the trust of Pharmaceutical fraternity. A. Baur & Co. (Pvt.) Ltd. is actively engaged in various industries over the span of 122 years and Baurs Healthcare division markets a range of world-renowned brands from leading MNC’s and reputed manufacturers which includes some of the leading pharmaceutical brands in Sri Lanka. Since its inception in 1945 Baurs Healthcare Division has proven its commitment to the country while preserving the company values and ethics as the name ‘Baurs’ stands for trust and reliability, quality and innovation. Rolf has a corporate career spanning over three decades, with experience in Europe and Southeast Asia and has a strong cross-cultural competency and brings a passion for operational excellence. With his new appointment as Hon. Secretary Rolf aims tirelessly for the betterment of the industry in making quality pharmaceutical products accessible to Sri Lankan patients at affordable prices. SLCPI is currently serving as the representative of over 60 members, who account for more than 80 percent of the private pharmaceutical industry, the SLCPI spans manufacturers, importers, distributors and retailers. These stakeholders supply Sri Lankan patients with 800 molecules from 364 manufacturers located across the world.